Fortis Healthcare Ltd
Fortis Healthcare Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #31 of 32 in Healthcare Services
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
2 of 3 strong
The short version
Fortis Healthcare remains fully committed to its growth plans and views Fortis as the growth engine for IHH's India platform. Fortis Healthcare, supported by IHH, remains fully committed to growth with plans for capital infusion as needed.
From Fortis Healthcare Ltd's Q1 FY27 earnings-call transcript · updated 18 Sept 2026.
Revenue & Sales Performance
- Fortis Healthcare remains fully committed to its growth plans and views Fortis as the growth engine for IHH's India platform.
- IHH Healthcare has the ability and willingness to invest additional capital as needed for Fortis' expansion, including brownfield projects and M&A opportunities.
- Operationally, Fortis has built a resilient and fully operational leadership team insulated from ongoing legal proceedings, ensuring steady execution.
- Competitive intensity in the healthcare sector is increasing; Fortis plans to step up efforts to maintain and grow its market position.
2 more points from Fortis Healthcare Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Fortis Healthcare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- IHH remains fully committed to Fortis Healthcare and its growth plans.
- There is no change in commitment to invest capital as needed for Fortis' expansion.
- IHH can infuse more capital within legal limits over the next 6 to 12 months and beyond.
- Growth plans including brownfield expansion and M&A activities will continue actively.
- IHH has no impediments to investing in Fortis and supporting its growth engine in India.
- The recent legal and forensic audit developments do not restrict corporate actions or capital infusion by IHH.
2 more points from Fortis Healthcare Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Fortis Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Fortis Healthcare Ltd said on order book & pipeline — free account, 30 seconds.
Fortis Healthcare Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.4K Cr, net profit ₹271 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fortis Health.'s management said in earlier quarters
Others in Healthcare Services this season
- Aatmaj Health (Q1 FY27)
Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again
- Asarfi Hospital Ltd (Q1 FY27)
Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) . Key investor presentation takeaways from Asarfi Hospital Ltd's Q
- KMC Speciality (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Fortis Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fortis Healthcare Ltd Q1 FY27 results?
Fortis Healthcare remains fully committed to its growth plans and views Fortis as the growth engine for IHH's India platform. Fortis Healthcare, supported by IHH, remains fully committed to growth with plans for capital infusion as needed.
What is Fortis Healthcare Ltd share price analysis?
Fortis Healthcare Ltd currently shows a below-average growth signal. The stock trades at a P/E of 62.8 with a market cap of ₹67,025 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fortis Healthcare Ltd planning capital expenditure?
IHH remains fully committed to Fortis Healthcare and its growth plans.
Keep Fortis Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.